Sanofi (EPA:SAN)

France · Delayed Price · Currency is EUR

103.40

+1.54 (1.51%)

Mar 28, 2025, 5:35 PM CET

Sanofi Employees

Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.

Employees

82,878

Change (1Y)

-3,210

Growth (1Y)

-3.73%

Revenue / Employee

€534,352

Profits / Employee

€67,087

Market Cap

126.57B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	82,878	-3,210	-3.73%
Dec 31, 2023	86,088	-5,485	-5.99%
Dec 31, 2022	91,573	-3,869	-4.05%
Dec 31, 2021	95,442	-3,970	-3.99%
Dec 31, 2020	99,412	-997	-0.99%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Related Stocks

Company Name	Employees
EssilorLuxottica Société anonyme	153,498
Sartorius Stedim Biotech	9,901
bioMérieux	13,982
Eurofins Scientific SE	62,696
Ipsen	5,358
Virbac	5,459
emeis Société anonyme	77,954
Clariane SE	61,798

Employee Rankings

Sanofi News

4 hours ago - Sanofi gets FDA nod for its hemophilia treatment - Seeking Alpha
5 hours ago - US FDA approves Sanofi's bleeding disorder therapy - Reuters
9 hours ago - AbbVie Vs. Sanofi: Which Is The Better Investment Right Now - Seeking Alpha
17 hours ago - Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD - GlobeNewsWire
1 day ago - Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate - Fortune
2 days ago - Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA - GlobeNewsWire
3 days ago - Sanofi gets priority review for its multiple sclerosis treatment by FDA - Seeking Alpha
3 days ago - Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis - GlobeNewsWire